Welcome to Pharmaceutical Online Live – An interactive forum to discuss some of the most important technologies and trends impacting the drug manufacturing space.
Throughout the year, we'll sit down with industry experts to discuss how pharmaceutical companies are tackling the challenges they face in developing, manufacturing, packaging, and distributing FDA-approved small molecule drug products. These discussions will include Q&A sessions with attendees. Each Pharmaceutical Online Live will be archived and accessible for registered site users.
BALANCING GLP-1 QUALITY WITH DEMAND
Balancing GLP-1 Quality With Demand
The global market for GLP-1 drugs is forecasted to bring in $156.71 billion in 2030, nearly tripling in size from $53.46 billion in 2025, with an estimated 17.46% CAGR.* Recent surges in demand put some GLP-1 drugs on shortage lists, leading to compounded versions that to...
CONTAMINATION CONTROL STRATEGIES FOR DRUG MANUFACTURERS
Contamination Control Strategies For Drug Manufacturers
Rushing into small molecule batch production without a comprehensive strategy for contamination control could end up costing a lot more money — and burning up a lot more time — than getting it right up front. Join Pharmaceutical Online for a live discussion wi...
FACILITY DESIGN AND VALIDATION CONSIDERATIONS FOR DRUG MANUFACTURERS
Facility Design And Validation Considerations For Drug Manufacturers
Whether you were breaking ground on a brand-new manufacturing facility or looking to upgrade an existing site, there were a dizzying number of factors to consider. For questions on everything from construction sequence to HVAC systems, utilities, designing single-use proc...
OPPORTUNITIES FOR INNOVATION IN PEPTIDE MANUFACTURING
Opportunities For Innovation In Peptide Manufacturing
While advances have been made in yield and purity, peptide manufacturing technology and infrastructure is aging, and the explosion of GLP-1 drugs has pushed it to capacity. Explore ways to improve peptide manufacturing to produce higher yields at lower costs and make...
MEET YOUR HOST
Katie Anderson,
Chief Editor, brings nearly two decades of editorial experience in business-to-business media. After earning her master’s degree in journalism, she began her career at the personal care R&D trade journal Cosmetics & Toiletries. There, she thrived on the constant flow of knowledge gained from interviewing chemists, regulatory experts, formulators and testing professionals in the field.
After nearly eight years with Cosmetics & Toiletries, Katie pursued her passion for skin physiology and ingredient science as Managing Editor of the professional esthetics brand Skin Inc. That same year, she also took on the role of Conference Director for Face and Body, where she developed and managed the event’s educational programming.
Following an acquisition, Katie was promoted to Editor-in-Chief of five professional media brands: Nailpro, Skin Inc., Beauty Launchpad, Medical Esthetics, and WellSpa 360.
Throughout her 19-year editorial career, Katie has held a variety of roles, but her passion has always been scientific editorial. She is the recipient of a bronze Folio Eddie Award for a single science article. She has frequently contributed her expertise as a guest speaker on industry podcasts, webcasts, conferences and video interviews. A lifelong learner, she enjoys the challenge of translating complex technical content into material that is both accurate and accessible.